Hormonal Control of Breast Cancer Cell Cycle Progression

[1]  J. A. Hamilton,et al.  Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. , 1993, Molecular and cellular biology.

[2]  R. Sutherland,et al.  Acute effects of growth factors on T-47D breast cancer cell cycle progression. , 1993, European journal of cancer.

[3]  K. Keyomarsi,et al.  Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. , 1992, The Journal of biological chemistry.

[4]  A. Stewart,et al.  Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen. , 1992, British Journal of Cancer.

[5]  W. Kruijer,et al.  Direct stimulation by estrogen of growth factor signal transduction pathways in human breast cancer cells , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[6]  L. Murphy,et al.  Mechanisms of growth inhibition by antiestrogens and progestins in human breast and endometrial cancer cells , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  A T Look,et al.  Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. , 1992, Genomics.

[8]  K. Horwitz,et al.  The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer? , 1992, Endocrine reviews.

[9]  B. Cheson,et al.  Retinoids in cancer therapy. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[11]  R. Sutherland,et al.  Regulation of breast cancer cell cycle progression by growth factors, steroids and steroid antagonists , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[12]  J. Foekens,et al.  Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors. , 1992, European journal of cancer.

[13]  E. Schuuring,et al.  Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. , 1992, Oncogene.

[14]  J G Klijn,et al.  The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. , 1992, Endocrine reviews.

[15]  Anthony Howell,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. , 1992 .

[16]  A. Harris.  p53 expression in human breast cancer. , 1992, Advances in cancer research.

[17]  I. Pastan,et al.  Recombinant toxins for cancer treatment. , 1991, Science.

[18]  B. Katzenellenbogen.  Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy. , 1991, Journal of the National Cancer Institute.

[19]  B. Kramer,et al.  Potential role of tamoxifen in prevention of breast cancer. , 1991, Journal of the National Cancer Institute.

[20]  O. Melnyk,et al.  Characterization of a candidate bcl-1 gene , 1991, Molecular and cellular biology.

[21]  R. Sutherland,et al.  Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes , 1991, Molecular and cellular biology.

[22]  T. Hunter,et al.  Cyclins and cancer , 1991, Cell.

[23]  S. Reed,et al.  Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast , 1991, Cell.

[24]  P. Watson,et al.  Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. , 1991, Cancer research.

[25]  L. Murphy,et al.  Differential regulation of c-myc by progestins and antiestrogens in T-47D human breast cancer cells , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[26]  Richard A. Ashmun,et al.  Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle , 1991, Cell.

[27]  M. J. van de Vijver,et al.  The molecular biology of breast cancer. , 1991, Biochimica et biophysica acta.

[28]  A. Arnold,et al.  A novel cyclin encoded by a bcl1-linked candidate oncogene , 1991, Nature.

[29]  D. Birnbaum,et al.  BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. , 1991, Oncogene.

[30]  E. Schuuring,et al.  D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. , 1991, Oncogene.

[31]  N. Kyprianou,et al.  Therapeutic Approaches to Activating Programmed Cell Death of Androgen-Independent Prostatic Cancer Cells , 1991 .

[32]  C. Osborne,et al.  Growth factors as mediators of estrogen/antiestrogen action in human breast cancer cells. , 1991, Cancer treatment and research.

[33]  R. Sutherland,et al.  Steroids, growth factors, and cell cycle controls in breast cancer. , 1991, Cancer treatment and research.

[34]  D. Yee,et al.  The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer. , 1991, Cancer treatment and research.

[35]  W. Lee,et al.  Role of the retinoblastoma gene in the oncogenesis of human breast carcinoma. , 1991, Cancer treatment and research.

[36]  N. Davidson,et al.  Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. , 1991, Cancer research.

[37]  M. Osborne,et al.  Neoplastic transformation of mouse mammary epithelial cells by deregulated myc expression. , 1990, Cell regulation.

[38]  P. Nurse.  Universal control mechanism regulating onset of M-phase , 1990, Nature.

[39]  G. Peters,et al.  Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. , 1990, European journal of cancer.

[40]  W. Gullick.  4. The role of the epidermal growth factor receptor and the c‐erbB‐2 protein in breast cancer , 1990 .

[41]  C. Theillet,et al.  Proto-oncogene amplification and human breast tumor phenotype. , 1989, Oncogene.

[42]  T. Frebourg,et al.  The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review). , 1989, Anticancer research.

[43]  R. Sutherland,et al.  Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle. , 1989, Cancer research.

[44]  L. Murphy,et al.  Regulation of Transforming Growth Factor α and Transforming Growth Factor β Messenger Ribonucleic Acid Abundance in T-47D, Human Breast Cancer Cells , 1989, Molecular Endocrinology.

[45]  J. Eisman,et al.  Effects of 1,25‐dihydroxyvitamin D3 on cell‐cycle kinetics of T 47D human breast cancer cells , 1989, Journal of cellular physiology.

[46]  G. Merlo,et al.  The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci. , 1989, Oncogene.

[47]  R. Sutherland,et al.  Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin. , 1989, Cancer research.

[48]  C. Clarke,et al.  Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. , 1988, Cancer research.

[49]  W. Blattner,et al.  Decreased progesterone binding and attenuated progesterone action in cultured human breast carcinoma cells treated with epidermal growth factor. , 1988, Cancer research.

[50]  G M Clark,et al.  Steroid receptors and other prognostic factors in primary breast cancer. , 1988, Seminars in oncology.

[51]  E. Gelmann,et al.  Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells. , 1988, Cancer research.

[52]  B. Henderson,et al.  Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. , 1988, Cancer research.

[53]  M. Blankenstein,et al.  Mitogenic stimulation of human breast cancer cells in a growth factor‐defined medium: Synergistic action of insulin and estrogen , 1988, Journal of cellular physiology.

[54]  R. Shiu,et al.  Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. , 1987, Cancer research.

[55]  R. Sutherland,et al.  Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro. , 1987, Cancer research.

[56]  Eric Wickstrom,et al.  A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1 , 1987, Nature.

[57]  D. Fabbro,et al.  Estrogen stimulates growth of mammary tumor cells ZR-75 without activation of S6 kinase and S6 phosphorylation. Difference from epidermal growth factor and alpha-transforming growth-factor-induced proliferation. , 1987, European journal of biochemistry.

[58]  H. Rochefort,et al.  Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. , 1987, Cancer research.

[59]  R. Dickson,et al.  Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. , 1987, Endocrine reviews.

[60]  J. Russo,et al.  Development of the Human Mammary Gland , 1987 .

[61]  R. Kingston,et al.  Inducible overproduction of the mouse c-myc protein in mammalian cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[62]  A. Nienhuis,et al.  Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[63]  P. Leder,et al.  Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes , 1984, Cell.

[64]  I. Taylor,et al.  Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells. , 1983, Cancer research.